October 27, 2022 12:54 PM EDT
R&D
Manufacturing

Man­u­fac­tur­ing roundup: Symeres buys CRO in New Jer­sey; Cam­brex in­vests $16M+ in Min­neso­ta and Iowa fa­cil­i­ties

Tyler Patchen

News Reporter

Dutch CD­MO Symeres has ac­quired a com­pa­ny to fur­ther strength­en its po­si­tion in the US.

The com­pa­ny is buy­ing Ex­em­pli­fy Bio­Phar­ma, a CRO that pro­vides …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times